Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
Journal of Neuroinflammation
|
October 30, 2016
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
Sven Jarius, Klemens Ruprecht, Ingo Kleiter, et al.
Therapeutic Advances in Neurological Disorders
|
June 9, 2021
Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies
Pietro Iaffaldano, Giuseppe Lucisano, Francesca Caputo, et al.
Multiple Sclerosis and Related Disorders
|
June 8, 2022
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis
Marta Ponzano, Irene Schiavetti, Francesca Bovis, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
January 20, 2022
Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study
Pietro Iaffaldano, Giuseppe Lucisano, Alessia Manni, et al.
Journal of Neurology
|
September 20, 2019
Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register
Damiano Paolicelli, Giuseppe Lucisano, Alessia Manni, et al.
European Journal of Neurology
|
September 24, 2021
A real-world study of alemtuzumab in a cohort of Italian patients
Cinzia Valeria Russo, Francesco Saccà, Jessica Frau, et al.
Journal of Neuroinflammation
|
January 21, 2022
Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients
Sven Jarius, Florence Pache, Peter Körtvelyessy, et al.
The Lancet. Neurology
|
August 21, 2021
Myelin-oligodendrocyte glycoprotein antibody-associated disease
Romain Marignier, Yael Hacohen, Alvaro Cobo-Calvo, et al.
Journal of Neurology
|
February 22, 2021
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study
Sebastiano Bucello, Pietro Annovazzi, Paolo Ragonese, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 19, 2025
Real-Life Evaluation of the MOGAD Diagnostic Criteria: Application Challenges and Discrepancies
Sara Carta, Elia Sechi, Alessandro Dinoto, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
Journal of Neuroinflammation
|
October 30, 2016
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
Sven Jarius, Klemens Ruprecht, Ingo Kleiter, et al.
Therapeutic Advances in Neurological Disorders
|
June 9, 2021
Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies
Pietro Iaffaldano, Giuseppe Lucisano, Francesca Caputo, et al.
Multiple Sclerosis and Related Disorders
|
June 8, 2022
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis
Marta Ponzano, Irene Schiavetti, Francesca Bovis, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
January 20, 2022
Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study
Pietro Iaffaldano, Giuseppe Lucisano, Alessia Manni, et al.
Journal of Neurology
|
September 20, 2019
Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register
Damiano Paolicelli, Giuseppe Lucisano, Alessia Manni, et al.
European Journal of Neurology
|
September 24, 2021
A real-world study of alemtuzumab in a cohort of Italian patients
Cinzia Valeria Russo, Francesco Saccà, Jessica Frau, et al.
Journal of Neuroinflammation
|
January 21, 2022
Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients
Sven Jarius, Florence Pache, Peter Körtvelyessy, et al.
The Lancet. Neurology
|
August 21, 2021
Myelin-oligodendrocyte glycoprotein antibody-associated disease
Romain Marignier, Yael Hacohen, Alvaro Cobo-Calvo, et al.
Journal of Neurology
|
February 22, 2021
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study
Sebastiano Bucello, Pietro Annovazzi, Paolo Ragonese, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 19, 2025
Real-Life Evaluation of the MOGAD Diagnostic Criteria: Application Challenges and Discrepancies
Sara Carta, Elia Sechi, Alessandro Dinoto, et al.
Page
of 8